11th December 2018: Proton Partners International announced today that the Rutherford Cancer Centre South Wales has been approved by the Welsh Health Specialised Services Committee (WHSSC) to provide high energy proton beam therapy to adult patients referred from the NHS in Wales.
27th November 2018: A new report by the Health Foundation has rightly highlighted the urgent need for a revolution in cancer diagnosis in Britain, Proton Partners International said today.
13th November 2018: A court case in the United States which ended in a £20 million damages award for the family of a patient who died from cancer after being denied proton beam therapy (PBT) has highlighted the importance of recognising PBT as a well-established treatment.
8th November 2018: The demand for proton beam therapy for cancer patients has increased significantly this year as a result of the availability of the treatment in the UK.
18th October 2018 – Medical innovation in the UK was given a significant boost today with the announcement that an advanced diagnostics centre is to be built in Liverpool.
3rd October 2018: Cancer care in the South of England took a significant step forward today with the opening of the Rutherford Cancer Centre Thames Valley.
21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
The independent inspectorate and regulator of healthcare in Wales visited the centre earlier this month, which will bring the most advanced treatments in cancer care to South Wales using innovative proton beam therapy. Approval was granted today following stringent checks and was the final point required ahead of the first patient being treated with high energy proton beam therapy in early April.
Proton Partners International Ltd opened its landmark Rutherford Cancer Centre in Newport earlier this year. The centre brings the most advanced treatments in cancer care to South Wales, including high energy proton beam therapy which is estimated by Proton Partners as being of benefit to around 10% of cancer patients throughout the UK.
Mike Moran, chief executive officer of Proton Partners International, said: “We are delighted that Healthcare Inspectorate Wales has approved the UK’s first high energy proton beam therapy system at our Rutherford Cancer Centre in Newport. This will lead the way for the first patient to be treated at the centre next month, and we are proud to be spearheading the introduction of this innovative cancer treatment within the UK.
“For us, this is the first step in ensuring that UK patients who need proton beam therapy do not need to travel abroad to receive treatment – something which is all the more important with cancer rates continuing to rise, and with research indicating that proton therapy has significantly lower side effects than traditional cancer treatments.”
The Rutherford Cancer Centres offer all-encompassing cancer services, including high energy proton beam therapy, radiotherapy, chemotherapy, immunotherapy, imaging and wellbeing services.
Treatment at the Rutherford Cancer Centre South Wales will be available to medically-insured private patients, self-paying patients and referrals by NHS Wales.